UPDATE : Saturday, February 22, 2020
Will Takeda, Dong-A ST benefit from new hypertension guideline? by Nam Doo-hyun 2017-12-19 16:15
Allergan, Gedeon Richter prove efficacy of bipolar drug in pivotal trial by Marian Chu 2017-12-19 15:26
New migraine drugs prepare to hit domestic market by Lee Hye-seon 2017-12-19 15:26
AstraZeneca aims to make Tagrisso 1st-line lung cancer therapy by Marian Chu 2017-12-19 14:36
Boehringer Ingelheim Korea’s labor union protests early retirement program by Nam Doo-hyun 2017-12-19 14:35
Daehwa Pharma launches clinical trial for breast cancer treatment by Lee Han-soo 2017-12-18 16:59
Green Cross unveils non-clinical trial data for hemophilia A treatment by Lee Han-soo 2017-12-18 15:12
Kwangdong punished for illegal ad of obesity drug by Lee Hye-seon 2017-12-18 14:50
Yuhan’s chemo combo YH24931 more effective than immunotherapy alone by Nam Doo-hyun 2017-12-18 11:51
‘Postmenopausal women in 50s shouldn’t take phytoestrogen’ by Nam Doo-hyun 2017-12-18 10:49
3 Korean startups using AI to develop new drugs by Marian Chu 2017-12-15 23:00
Medytox, Hugel compete in botulinum toxin market by So Jae-hyeon 2017-12-15 15:12
Parkinson’s disease treatment Azilect in robust growth by So Jae-hyeon 2017-12-15 11:36
Ildong, Abbot to tap rosuvastatin+ezetimibe combo market by Lee Hye-seon 2017-12-14 15:01
Koreans in their 20s most susceptible to hepatitis A: study by Marian Chu 2017-12-13 18:18
MGmed to change name to Cancer Rop by Marian Chu 2017-12-13 18:14
Syntekabio, CJ Healthcare agree to develop new drugs using AI by Lee Han-soo 2017-12-13 17:17
Daewoong’s liver drug Ursa to enter US market by So Jae-hyeon 2017-12-13 15:23
Janssen says its multiple myeloma drug combo halves death risk by Marian Chu 2017-12-13 15:22
Celgene, Bluebird Bio’s CAR-T therapy proves 94% response in P1 study by Marian Chu 2017-12-13 14:30
Back to Top